文献速递类风湿关节炎血管炎其他结缔组织病

自身免疫性疾病患者的侵袭性真菌病:法国RESSIF网络病例系列

Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network.
PubMed 文献 · RMD Open · 2023-01-01

基于法国RESSIF登记网络2012至2018年数据,纳入549例合并侵袭性真菌病的自身免疫性疾病患者,以肺孢子菌肺炎、真菌血症和侵袭性曲霉病为主。30天死亡率为28.1%(143/508),真菌血症和高剂量糖皮质激素与30天死亡率升高独立相关。肺孢子菌肺炎患者中淋巴细胞减少常见,但CD4+T细胞计数超过200/mm3者占71.8%。

要点

  • 自身免疫病患者合并侵袭性真菌病以肺孢子菌肺炎(41.3%)、真菌血症(30.4%)和侵袭性曲霉病(15.5%)为主。
  • 30天死亡率为28.1%(143/508),真菌血症和高剂量糖皮质激素与30天死亡率升高独立相关。
  • 肺孢子菌肺炎患者中CD4+T细胞计数超过200/mm3者占71.8%,正常CD4+T细胞计数不能排除肺孢子菌肺炎风险。

核心结论

  • 自身免疫病相关侵袭性真菌病主要发生于类风湿关节炎、ANCA相关性血管炎和炎症性肠病患者,尤其在使用糖皮质激素和免疫抑制剂时。
  • 死亡率高,尤其是使用高剂量糖皮质激素的患者。
  • 淋巴细胞减少可能有助于识别肺孢子菌肺炎风险,但CD4+T细胞计数正常不能排除该风险。
  • 需要进一步研究评估侵袭性真菌病的个体危险因素。

研究设计与样本

  • 分析法国国家侵袭性真菌病参考中心RESSIF登记网络中2012至2018年自身免疫病相关侵袭性真菌病病例。
  • 研究自身免疫病特异性治疗与30天死亡率的关联。
  • 分析肺孢子菌肺炎患者的淋巴细胞总数和CD4+T细胞计数。
  • 共纳入549例合并侵袭性真菌病的自身免疫病患者。

主要发现

  • 肺孢子菌肺炎227例(41.3%),真菌血症167例(30.4%),侵袭性曲霉病84例(15.5%)。
  • 肺孢子菌肺炎中最常见的自身免疫病为类风湿关节炎(55例)和ANCA相关性血管炎(25例),侵袭性曲霉病中分别为15例和10例,真菌血症中以炎症性肠病为主(36例)。
  • 诊断侵袭性真菌病时,365例(66.5%)使用糖皮质激素,285例(51.9%)使用免疫抑制剂,42例(7.7%)使用TNF-α抑制剂,75例(13.7%)使用其他生物制剂。
  • 30天死亡率为28.1%(143/508)。
  • 真菌血症和高剂量糖皮质激素与30天死亡率升高独立相关。

局限性

  • 需要进一步研究评估侵袭性真菌病的个体危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to describe patients with autoimmune diseases (AID) developing invasive fungal disease (IFD) and identify factors associated with short-term mortality. METHODS: We analysed cases of IFD associated with AID from the surveillance network of invasive fungal diseases (Réseau de surveillance des infections fongiques invasives, RESSIF) registry of the French national reference centre for invasive mycoses. We studied association of AID-specific treatments with 30-day mortality. We analysed total lymphocyte and CD4-T cell counts in patients with Pneumocystis jirovecii pneumonia (PCP). RESULTS: From 2012 to 2018, 549 individuals with IFD and AID were included, mainly with PCP (n=227, 41.3%), fungemia (n=167, 30.4%) and invasive aspergillosis (n=84, 15.5%). Rheumatoid arthritis (RA) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) were the most frequent AID in PCP (n=55 and 25, respectively) and invasive aspergillosis (n=15 and 10, respectively), inflammatory bowel diseases (IBDs) were predominant in fungemia (n=36). At IFD diagnosis, 365 (66.5%) patients received glucocorticoids (GCs), 285 (51.9%) immunosuppressants, 42 (7.7%) tumor necrosis factor (TNF)-α blockers, 75 (13.7%) other biologics. Mortality at 30 days was 28.1% (143/508). Fungemia and high-dose GCs were independently associated with higher 30-day mortality. In PCP patients, lymphopenia <1500/mm3 was frequent (132/179, 73.7%) even if CD4+T cell count exceeded 200/mm3 in 56/78 patients (71.8%) (median 472.5/mm3, IQR 160-858). CONCLUSION: IFD associated with AID occurs primarily in RA, AAV and IBD, especially when treated with GCs and immunosuppressants. Mortality is high, especially for patients on high-dose GCs. Lymphopenia may help identify risk of PCP, but normal CD4+T cell count does not rule out the risk. Further studies are needed to assess the individual risk factors for IFD.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Galmiche S, Thoreau B, Bretagne S, et al. Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network. RMD Open. 2023. PMID: 37558492. doi:10.1136/rmdopen-2023-003281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。